CLINICAL_TRIALS
withdrawal
· 2015-12-04
Clinical Trial Update: Calcitonin in the Treatment of Fibromyalgia [Phase 4]
Summary
A Phase 4 clinical trial investigating calcitonin for fibromyalgia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unidad de Investigacion en Enfermedades Cronico-Degenerativas | Conditions: Fibromyalgia | Phase 4 | Status: WITHDRAWN